Cover Image
市場調查報告書

眼科用醫療設備市場預測 (2016-2026年):眼科手術、診斷&監測、視力保健用產品的展望、發展

Ophthalmic Devices Market Forecast 2016-2026: Clarifying Vision - Prospects and Developments in Ophthalmic Surgical Devices, Diagnostics and Monitoring, and Vision Care

出版商 Visiongain Ltd 商品編碼 305155
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
眼科用醫療設備市場預測 (2016-2026年):眼科手術、診斷&監測、視力保健用產品的展望、發展 Ophthalmic Devices Market Forecast 2016-2026: Clarifying Vision - Prospects and Developments in Ophthalmic Surgical Devices, Diagnostics and Monitoring, and Vision Care
出版日期: 2016年05月10日 內容資訊: 英文 190 Pages
簡介

全球眼科用醫療設備的收益規模預計到2020年成長到227億4000萬美元的規模。人口的高齡化與其伴隨的糖尿病,眼併發症的增加,新興經濟圈的急速成長,新技術的崛起等要素,在預測期間內帶來高收益成長。

本報告提供眼科用的各種醫療設備的市場調查,眼結構、功能及眼的疾病相關概要,眼科用醫療設備種類與概要,各種類的市場規模的變化與預測,SWOT分析,主要企業及主要產品,主要國家市場的趨勢、預測,定性分析,未來展望等彙整資料。

第1章 報告概要

第2章 眼科用醫療設備的市場:簡介

  • 眼結構、功能概要
  • 全球眼病患的負擔
  • 眼科疾病
  • 眼科用醫療設備的區分
  • 眼科用醫療設備

第3章 全球市場的預測

  • 市場概要
  • 市場成果:各種類
  • 市場預測

第4章 眼科手術用設備、用具:市場預測

  • 市場概要
  • 市場預測
    • 人工水晶體
    • 眼科雷射
    • 眼粘性子彈劑
    • 水晶體乳化吸引設備
    • 其他
    • 藥物輸送設備
  • SWOT分析

第5章 視力保健設備:市場預測

  • 市場概要
  • 市場預測
  • 隱形眼鏡
  • 隱形眼鏡市場:新產品的開發、產品平台
  • SWOT分析

第6章 眼科診斷、監測用設備:市場預測

  • 市場概要
  • 市場成果
  • 市場預測:各種類
    • OCT機器
    • 自動驗光儀/角膜測量儀
    • 眼底攝影機
    • 裂隙燈
    • 其他
  • SWOT分析

第7章 主要國家市場預測

  • 主要國家市場成果
  • 主要國家市場預測
    • 美國
    • 歐盟5國
    • 日本
    • 中國
    • 印度
    • 俄羅斯
    • 巴西
    • 韓國

第8章 主要企業

  • Alcon (Novartis)
  • Abbott Medical Optics (AMO)
  • Bausch and Lomb (B&L) (Valeant)
  • Johnson & Johnson Vision Care
  • Nidek
  • HOYA
  • STAAR Surgical (STAAR)
  • Carl Zeiss AG Meditec
  • Topcon Corporation
  • Haag-Streit Holding AG
    • 財務成果
    • 產品線等

第9章 定性分析

  • 波特的五力分析

第10章 總論

第11章 用語

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0115

What can be expected from the Ophthalmic Devices Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.

Our 190-page report provides 124 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across the all the major categories of the ophthalmic devices market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects

Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter's Five Forces analysis) and commercial developments.

See revenue forecasts for the leading submarkets

How will submarkets perform to 2026? Our study forecasts revenues in the following Ophthalmic Devices submarkets:

  • Surgical Devices
  • Diagnostics and Monitoring Devices
  • Vision Care

See detailed profiles or revenue forecasts for some the leading products in the market

How will leading devices perform to 2026? Our study provides detailed profiles or forecasts revenues for a number of devices and product segments in the ophthalmic devices market including:

  • Intraocular Lenses
  • Ophthalmic Lasers
  • Ophthalmic Viscoelastic Devices
  • Phacoemulsification Devices
  • Daily Disposable Contact Lenses
  • Autrorefractors/Keratometers
  • OCT Machines
  • Fundus Cameras
  • Slit Lamps

See revenue forecasts for the leading national markets

How will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets including products, including:

  • US
  • EU5 - Germany, UK, France, Italy and Spain
  • China
  • Japan
  • India
  • Russia
  • Brazil
  • South Korea

Leading companies and potential for market growth

Visiongain forecasts overall revenue for the Ophthalmic Devices Market will reach $22.84bn in 2020. We predict a high revenue growth over the forecast period driven by an aging population, with a higher incidence of diabetes resulting in related ocular complications, rapid growth of emerging economies and emerging devices technologies.

Our work analyses the key companies in the market. See visiongain's analysis of ten leading companies, including these:

  • Alcon
  • Abbott Medical Optics (AMO)
  • Bausch and Lomb (B&L)
  • Johnson & Johnson (J&J)
  • Nidek
  • Hoya
  • STAAR
  • Carl Zeiss AG Meditec
  • TopCon
  • Haag-Streit Holding AG

A company profile gives you the following information where available:

  • Discussion of a company's activities and outlook
  • Historic revenue, analysis and discussion of company performance
  • Analysis of major products currently on the market
  • Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the ophthalmic devices industry?

Our new report discusses issues and events affecting the ophthalmic devices market. You will find discussions, including qualitative analyses:

  • Highly consolidated and competitive market with significant variations in different geographic regions
  • Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities
  • Future paradigm-shifting pipeline products

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Ophthalmic Devices Market Forecast 2016-2026: Clarifying Vision - Prospects and Developments in Ophthalmic Surgical Devices, Diagnostics and Monitoring, and Vision Care report helps you

In summary, our 190-page report gives you the following knowledge:

  • Revenue forecasts to 2026 for the Ophthalmic Devices market - discover the industry's prospects, finding promising places for investments and revenues
  • Revenue forecasts to 2026 for each major submarket - discover prospects for leading ophthalmic devices in the following areas: surgical devices, vision care, and diagnostics and monitoring devices.
  • Detailed profiles or revenue forecasts to 2026 for 9 of the leading product areas in the ophthalmic devices market - discover prospects for leading ophthalmic devices products: Intraocular Lenses, Ophthalmic Laser, Ophthalmic Viscoelastic Devices, Phacoemulsification Devices, Daily Disposable Contact Lenses, Autorefractor/Keratometers, OCT Machines, Fundus Cameras, and Slit Lamps.
  • Revenue forecasts to 2026 for twelve leading national market and one leading regional markets - US, EU5, China, Japan, India, Russia, Brazil, and South Korea.
  • Assessment of ten leading companies - analysis of products, revenue, mergers & acquisitions, product type and product pipelines
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the ophthalmic devices market and leading companies. You will find data, trends and predictions. Please order our report now.

visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Ophthalmic Devices Market Overview
  • 1.2. Global Ophthalmic Devices Market Segmentation
  • 1.3. Overview of Findings
  • 1.4. Structure of the Report
  • 1.5. Why You Should Read This Report
  • 1.6. How This Report Delivers
  • 1.7. Key Questions Answered by This Analytical Report
  • 1.8. Who is This Report For?
  • 1.9. Methodology
  • 1.10. Frequently Asked Questions (FAQ)
  • 1.11. Associated Visiongain Reports
  • 1.12. About Visiongain

2. Introduction to the Ophthalmic Devices Market

  • 2.1. The Eye: An Overview of its Structure and Function
  • 2.2. The Global Burden of Eye Disease
  • 2.3. Eye Diseases
    • 2.3.1. Refractive Errors (Myopia, Hyperopia or Astigmatism)
    • 2.3.2. Cataracts
    • 2.3.3. Glaucoma
      • 2.3.3.1. Diagnosis of Glaucoma
    • 2.3.4. Age-Related Macular Degeneration (AMD)
      • 2.3.4.1. Dry (Non-Exudative) AMD
      • 2.3.4.2. Wet (Exudative) AMD
    • 2.3.5. Diabetic Retinopathy (DR)
      • 2.3.5.1. Diagnosis of Diabetic Retinopathy
    • 2.3.6. Dry Eye Syndrome (DES)
  • 2.4. Ophthalmic Devices: Market Segmentation
    • 2.4.1. The Monitoring and Diagnostics Ophthalmic Devices Market
      • 2.4.1.1. General Eye Health Monitoring Devices
      • 2.4.1.2. Refractive Error Monitoring and Diagnostics Devices
      • 2.4.1.3. Glaucoma Monitoring and Diagnostic Devices
    • 2.4.2. The Surgical Ophthalmic Devices Market
      • 2.4.2.1. Refractive Error Surgery Devices
        • 2.4.2.1.1. LASIK Eye Surgery (Laser In-Situ Keratomileusis)
        • 2.4.2.1.2. Photorefractive Keratectomy (PRK)
        • 2.4.2.1.3. Phakic Intraocular Surgery
        • 2.4.2.1.4. Conductive Keratoplasty (CK)
        • 2.4.2.1.5. Refractive Lens Exchange (RLE)
        • 2.4.2.1.6. Vitreoretinal Surgery Devices
      • 2.4.2.2. Cataract Surgery Devices
        • 2.4.2.2.1. Phacoemulsification and Intraocular Lenses
        • 2.4.2.2.2. Microincision Cataract Surgery (MICS)
      • 2.4.2.3. Glaucoma Surgical Devices
        • 2.4.2.3.1. Glaucoma Lasers
        • 2.4.2.3.2. Other Glaucoma Surgical Devices
      • 2.4.2.4. Age-Related Macular Degeneration (AMD) Surgical Devices
        • 2.4.2.4.1. Photodynamic Therapy
        • 2.4.2.4.2. Laser Photocoagulation
        • 2.4.2.4.3. Radiotherapy-Oraya Therapy
        • 2.4.2.4.4. Newer Types of Surgery
      • 2.4.2.5. Diabetic Retinopathy Surgery Devices
      • 2.4.2.6. Dry Eye Syndrome Surgery Devices
        • 2.4.2.6.1. Punctal Occlusion
        • 2.4.2.6.2. Salivary Gland Autotransplantation
        • 2.4.2.6.3. Tarsorrhaphy
    • 2.4.3. The Vision Care Devices Market
  • 2.5. Ophthalmic Devices
    • 2.5.1. What are Ophthalmic Devices?
    • 2.5.2. Devices: Classification
      • 2.5.2.1. The US Medical Devices Classification System
      • 2.5.2.2. The EU Medical Devices Classification System
      • 2.5.2.3. The Japanese Medical Devices Classification System
    • 2.5.3. Regulation of Ophthalmic Devices
      • 2.5.3.1. The US Approval and Regulation System
      • 2.5.3.2. The EU Approval and Regulation System
      • 2.5.3.3. The Japanese Approval and Regulation System

3. The Global Ophthalmic Devices Market, 2016-2026

  • 3.1. The Medical Devices Market Overview
    • 3.1.1. The Global Medical Devices Market, 2016-2026
  • 3.2. The Ophthalmic Devices Market by Submarket, 2016
  • 3.3. The Ophthalmic Devices Market, 2016-2026

4. The Ophthalmic Surgical Devices Market, 2016-2026

  • 4.1. The Ophthalmic Surgical Devices Market Overview
    • 4.1.1. The Surgical Ophthalmic Devices Market, 2015
  • 4.2. The Surgical Ophthalmic Devices Market Forecast, 2016-2026
    • 4.2.1. The Intraocular Lenses Market Forecast, 2016-2026
      • 4.2.1.1. Intraocular Lens Products
      • 4.2.1.2. Intraocular Lenses Product Pipeline
        • 4.2.1.2.1. The Light Adjustable Lens (Calhoun)
        • 4.2.1.2.2. LiquiLens IOL (Vision Solution Technologies)
        • 4.2.1.2.3. Smart IOL (Medennium)
        • 4.2.1.2.4. NuLens Accommodating IOL (NuLens)
        • 4.2.1.2.5. The FluidVision Lens (PowerVision)
    • 4.2.2. The Ophthalmic Laser Market Forecast, 2016-2026
      • 4.2.2.1. Refractive Lasers
        • 4.2.2.1.1. STAR S4 IR Excimer Laser (Abbott Medical Optics)
        • 4.2.2.1.2. iFS Advanced Femtosecond Laser (Abbott Medical Optics)
        • 4.2.2.1.3. WaveLight Allegretto Wave Eye-Q Laser (Alcon (Novartis))
        • 4.2.2.1.4. WaveLight Refractive Suite (Alcon (Novartis))
        • 4.2.2.1.5. NIDEK Advanced Vision Excimer Laser System NAVEX Quest (Nidek)
        • 4.2.2.1.6. TECHNOLAS TENEO 317 Laser (Bausch and Lomb (Valeant))
        • 4.2.2.1.7. TECHNOLAS TENEO 217P Laser (Bausch and Lomb (Valeant))
      • 4.2.2.2. Cataract Lasers
        • 4.2.2.2.1. The LenSx Laser (Alcon (Novartis))
        • 4.2.2.2.2. LENSAR Laser System (LENSAR)
        • 4.2.2.2.3. Catalys Precision Laser System (Abbott Medical Optics)
        • 4.2.2.2.4. VICTUS Femtosecond Laser Platform (Bausch and Lomb Technolas)
        • 4.2.2.2.5. Lumenis Vision (InSight)
    • 4.2.3. The Ophthalmic Viscoelastic Devices Market, 2016-2026
    • 4.2.4. The Phacoemulsification Devices Market Forecast, 2016-2026
    • 4.2.5. The Other Surgical Ophthalmic Devices Market Forecast, 2016-2026
    • 4.2.6. Ophthalmic Drug Delivery Devices
      • 4.2.6.1. Recent Approvals
        • 4.2.6.1.1. Retisert Fluocinolone Acetonide (Bausch and Lomb)
        • 4.2.6.1.2. Ozurdex Dexamethasone (Allergan)
        • 4.2.6.1.3. Iluvien Fluocinolone Acetonide (Alimera Sciences)
      • 4.2.6.2. Novel Ocular Drug Delivery Platform Pipeline
        • 4.2.6.2.1. ECT Platform (Neurotech Pharmaceuticals)
        • 4.2.6.2.2. Hydrogel Technology Products (Ocular Therapeutix)
        • 4.2.6.2.3. ProDex (Taiwan Liposome Company)
      • 4.2.6.3. Microinvasive Glaucoma Surgery (MIGS)
        • 4.2.6.3.1. Trabectome (NeoMedix Corporation)
        • 4.2.6.3.2. EX-PRESS Glaucoma Filtration Devices (Alcon)
        • 4.2.6.3.3. iStent (Glaukos)
      • 4.2.6.4. Stents in the Glaucoma Pipeline
        • 4.2.6.4.1. CyPass Micro-Stent (Transcend Medical)
        • 4.2.6.4.2. Hydrus (Ivantis)
        • 4.2.6.4.3. XEN Gel Stent (Aquesys)
  • 4.3. SWOT Analysis of the Ophthalmic Surgical Devices Market, 2016-2026
    • 4.3.1. Strengths
      • 4.3.1.1. Highest Growing Submarket
      • 4.3.1.2. Fast Development of IOL Technology
      • 4.3.1.3. Increasingly Sophisticated Laser Surgery
    • 4.3.2. Weaknesses
      • 4.3.2.1. Challenging Reimbursement Environment
    • 4.3.3. Opportunities
      • 4.3.3.1. Ageing Population
      • 4.3.3.2. Rising Diabetes Epidemic
      • 4.3.3.3. Large Pipeline of Products
    • 4.3.4. Threats
      • 4.3.4.1. Pharmaceuticals Compete as Therapies for Ocular Diseases

5. The Ophthalmic Vision Care Devices Market, 2016-2026

  • 5.1. The Ophthalmic Vision Care Devices Market Overview
  • 5.2. The Ophthalmic Vision Care Devices Market, 2016-2026
    • 5.2.1. The Ophthalmic Vision Care Devices Market by Segment
      • 5.2.1.1. The Ophthalmic Vision Care Devices Market by Segment, 2015
      • 5.2.1.2. The Ophthalmic Vision Care Devices Market by Segment, 2016-2026
        • 5.2.1.2.1. The Daily Disposable Contact Lenses Market, 2016-2026
        • 5.2.1.2.2. The Others Contact Lenses Market, 2016-2026
  • 5.3. Contact Lenses on the Market
  • 5.4. The Contact Lenses Market: New Product Development and Product Pipeline
    • 5.4.1. Acuvue Oasys with HydraLuxe (Johnson & Johnson)
    • 5.4.2. 1-DAY ACUVUE MOIST Multifocal Lenses (Johnson & Johnson)
    • 5.4.3. ULTRA with MoistureSeal (Bausch and Lomb)
    • 5.4.4. 1-DAY ACUVUE DEFINE with LACERON Technology (Johnson & Johnson)
    • 5.4.5. Google Smart Lenses in cooperation with Novartis
    • 5.4.6. Samsung Patents Contact Lens with a Built-In Camera
    • 5.4.7. Sony Files Patent for Smart Contact Lenses which Can Store Data
    • 5.4.8. Sensimed (Triggerfish)
  • 5.5. SWOT Analysis of the Vision Care Market, 2016-2026
    • 5.5.1. Strengths
      • 5.5.1.1. Increasing Adoption of Disposable Contact Lenses
      • 5.5.1.2. Contact Lenses for Non-Ocular Disorders
      • 5.5.1.3. Linked to Changes in Consumer Spending
    • 5.5.2. Weaknesses
      • 5.5.2.1. High Entry Barriers for New Entry Manufacturers
      • 5.5.2.2. Fast Downward Pricing Pressure
    • 5.5.3. Opportunities
      • 5.5.3.1. Growing Affluent Population in Developing Economies
      • 5.5.3.2. Increasing Access to Diagnostic Equipment
      • 5.5.3.3. Sales of Cosmetic and Coloured Lenses
      • 5.5.3.3. Ageing population
    • 5.5.4. Threats
      • 5.5.4.1. Growing Demand for LASIK Surgery

6. The Ophthalmic Diagnostics and Monitoring Devices Market, 2016-2026

  • 6.1. The Ophthalmic Diagnostics and Monitoring Devices Market Overview
  • 6.2. The Ophthalmic Diagnostics and Monitoring Devices Market, 2015
  • 6.3. The Ophthalmic Diagnostics and Monitoring Devices Market Forecast by Segment, 2016-2026
    • 6.3.1. The OCT Machine Market Forecast, 2016-2026
      • 6.3.1.1. Ophthalmic OCT Machine Products
    • 6.3.2. The Autorefractor/Keratometer Market Forecast, 2016-2026
    • 6.3.3. The Fundus Camera Market Forecast, 2016-2026
    • 6.3.4. The Slit Lamp Market Forecast, 2016-2026
    • 6.3.5. The Other Ophthalmic Diagnostics and Monitoring Devices Market Forecast, 2016-2026
  • 6.4. SWOT Analysis of the Ophthalmic Diagnostics and Monitoring Devices Market, 2016-2026
    • 6.4.1. Strengths
      • 6.4.1.1. Continuing Development of Improved Technologies
      • 6.4.1.2. Stable Future Revenue through Lack of Pricing Pressure
    • 6.4.2. Weaknesses
      • 6.4.2.1. Shortage of Ophthalmic Device Providers
    • 6.4.3. Opportunities
      • 6.4.3.1. Ageing Population
      • 6.4.3.2. Increasing Demand for Advanced Optical Coherence Tomography Machines
      • 6.4.3.3. Increasing Demand for Advanced Ophthalmic Diagnostics
    • 6.4.4. Threats
      • 6.4.4.1. Increasing Cost of Healthcare

7. The Leading National Ophthalmic Devices Markets, 2016-2026

  • 7.1. The Leading National Ophthalmic Devices Markets, 2015
  • 7.2. The Leading National Ophthalmic Devices Markets, 2026
  • 7.3. The Leading National Ophthalmic Devices Market Forecast, 2016-2026
  • 7.4. The US Ophthalmic Devices Market Forecast, 2016-2026
  • 7.5. The EU5 Ophthalmic Devices Market, 2015
    • 7.5.1. The EU5 Ophthalmic Devices Market Forecast, 2016-2026
      • 7.5.1.1. The German Ophthalmic Devices Market Forecast, 2016-2026
      • 7.5.1.2. The French Ophthalmic Devices Market Forecast, 2016-2026
      • 7.5.1.3. The UK Ophthalmic Devices Market Forecast, 2016-2026
      • 7.5.1.4. The Italian Ophthalmic Devices Market Forecast, 2016-2026
      • 7.5.1.5. The Spanish Ophthalmic Devices Market Forecast, 2016-2026
  • 7.6. The Japanese Ophthalmic Devices Market Forecast, 2016-2026
  • 7.7. The Chinese Ophthalmic Devices Market Forecast, 2016-2026
  • 7.8. The Indian Ophthalmic Devices Market Forecast, 2016-2026
  • 7.8. The Russian Ophthalmic Devices Market Forecast, 2016-2026
  • 7.9. The Brazilian Ophthalmic Devices Market Forecast, 2016-2026
  • 7.10. The South Korean Ophthalmic Devices Market Forecast, 2016-2026

8. The Leading Ophthalmic Devices Companies, 2016

  • 8.1. Alcon (Acquired by Novartis)
    • 8.1.1. Alcon Financial Performance, 2014-2015
    • 8.1.2. Product Line
      • 8.1.2.1. Surgical Division Products
        • 8.1.2.1.1. CENTURION Vision System
        • 8.1.2.1.2. LenSx Laser
        • 8.1.2.1.3. WaveLight Refractive Suite
        • 8.1.2.1.4. WaveLight Allegretto Wave Eye-Q Laser
        • 8.1.2.1.5. ACRYSOF IOLS
        • 8.1.2.1.6. EX-PRESS Glaucoma Filtration Device
        • 8.1.2.1.7. INFINITI Vision System
      • 8.1.2.2. Vision Care Products
        • 8.1.2.2.1. AIR OPTIX
        • 8.1.2.2.2. FOCUS DAILIES
        • 8.1.2.2.3. FreshLook Colour Lenses
    • 8.1.3. Mergers and Acquisitions
      • 8.1.3.1. Novartis Acquisition of Alcon
      • 8.1.3.2. Acquisition of Endure Medical Systems
      • 8.1.3.3. Acquisition of SensoMotoric Instruments GmbH (SMI) - Ophthalmic Division
      • 8.1.3.4. Acquisition of LenSx Lasers
      • 8.1.3.5. Acquisition of WaveTec Vision
      • 8.1.3.6. Licensing of Google [X] Smart Lens Technology
      • 8.1.3.7. Acquistion of Transcend Medical Inc
  • 8.2. Abbott Medical Optics (AMO)
    • 8.2.1. AMO Financial Performance, 2014-2015
    • 8.2.2. AMO Product Portfolio
    • 8.2.3. Mergers and Acquisitions
      • 8.2.3.1. Abbott's Acquisition of Advanced Medical Optics
      • 8.2.3.2. Acquisition of OptiMedica
      • 8.2.3.3. Acquisition of VISX
  • 8.3. Bausch and Lomb (B&L) (Acquired by Valeant)
    • 8.3.1. Bausch and Lomb Financial Performance, 2015
    • 8.3.2. Vitreoretinal Surgical Products
      • 8.3.2.1. Retisert (fluocinolone acetonide intravitreal implant) 0.59mg.
    • 8.3.3. Cataracts Lens Products
      • 8.3.3.1. enVista Intraocular Lens (IOL)
      • 8.3.3.2. TRULIGN Toric IOL
      • 8.3.3.3. Akreos Advanced Optics (AO) and MICS Lens
      • 8.3.3.4. Crystalens AO Lens
      • 8.3.3.5. SofPort AO Aspheric Lens
    • 8.3.4. Cataracts Surgery Products
      • 8.3.4.1. Stellaris Vision Enhancement System
      • 8.3.4.2. VICTUS Femtosecond Laser Platform
    • 8.3.5. Mergers and Acquisitions
      • 8.3.3.1. Acquisition of Laboratorio Pförtner Cornealent SACIF
      • 8.3.3.2. Valeant's Acquisition of Bausch and Lomb
      • 8.3.3.3. Acquisition of Technolas Perfect Vision GmbH
      • 8.3.3.4. Acquisition of Eyeonics
      • 8.3.3.5. Bausch and Lomb's Price Fixing in China
      • 8.3.3.6. Bausch and Lomb Acquire Paragon Vision Care
      • 8.3.3.7. Bausch and Lomb Continue on Speciality Lens Shopping Spree by Acquiring Alden Optical
  • 8.4. Johnson & Johnson Vision Care
    • 8.4.1. Johnson and Johnson Vision Care Financial Performance, 2015
      • 8.4.1.1. Johnson and Johnson Vision Care Financial Performance, 2014-2015
    • 8.4.2. Product Line
    • 8.4.3. Expansion of Manufacturing Facilities
    • 8.4.4. Fined for Price Fixing Contact Lens in China
  • 8.5. Nidek
    • 8.5.1. Nidek Financial Performance
    • 8.5.2. Product Line
      • 8.5.2.1. Surgical Systems
      • 8.5.2.2. Intraocular Lens
      • 8.5.2.3. Ophthalmic Lasers
      • 8.5.2.4. Refractive Surgery Systems
      • 8.5.2.5. Diagnostic Equipment
        • 8.5.2.5.1. Retina and Glaucoma
        • 8.5.2.5.2. Cornea and Cataract
  • 8.6. Hoya Corporation
    • 8.6.1. Hoya Financial Performance, 2015
      • 8.6.1.1. Hoya Financial Performance by Business Segment, 2014
    • 8.6.2. IOL Product Lines
  • 8.7. STAAR Surgical (STAAR)
    • 8.7.1. STAAR Surgical Financial Performance, 2012-2015
    • 8.7.2. Product Line
      • 8.7.2.1. Intracollamer Lenses
      • 8.7.2.2. Intraocular Lenses
  • 8.8. Carl Zeiss AG Meditec
    • 8.8.1. Carl Zeiss Meditec Financial Performance, 2012-2016
      • 8.8.1.1. Carl Zeiss Meditec Financial Performance by Business Segment, 2015
      • 8.8.1.2. Carl Zeiss Meditec Financial Performance by Region, 2014
    • 8.8.2. Product Line
    • 8.8.3. Mergers and Acquisitions
      • 8.8.3.1. Acquisition of Aaren Scientific
      • 8.8.3.2. Cooperation Agreement with Oraya Therapeutics Inc
  • 8.9. TopCon
    • 8.9.1. TopCon Eye Care Company Financial Performance, 2015
      • 8.9.1.1. TopCon Financial Performance by Business Segment, 2015
    • 8.9.2. Product Line
      • 8.9.2.1. 3D OCT-2000 Spectral Domain OCT
      • 8.9.2.2. Other Major Products
    • 8.9.3. Mergers and Acquisitions
      • 8.9.3.1. Acquisition of Optimedica's Retina and Glaucoma Business
  • 8.10. Haag-Streit Holding AG
    • 8.10.1. Haag-Streit Holding AG Product Line

9. Qualitative Analysis of the Ophthalmic Devices Market, 2016-2026

  • 9.1. Porter's Five Forces Analysis of the Ophthalmic Devices Market
    • 9.1.1. Rivalry among Competitors [High]
    • 9.1.2. Threat of New Entrants [Medium]
    • 9.1.3. Power of Suppliers [Low]
    • 9.1.4. Power of Buyers [High]
    • 9.1.5. Threat of Substitutes [High]

10. Conclusions

  • 10.1. The World Ophthalmic Devices Market, 2015-2016
  • 10.2. Leading Ophthalmic Devices Submarkets
  • 10.3. World Ophthalmic Devices Market Forecast, 2016-2026
  • 10.4. Leading Segments of the Ophthalmic Devices Submarkets

11. Glossary

Appendix

  • Vision gain's Bespoke Research Service
  • Some Associated Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form

List of Tables

  • Table 1.1: Ophthalmic Devices Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 2.1: Segments and Definitions of the Ophthalmic Market
  • Table 2.2: Global Prevalence of Visual Impairment, 2016
  • Table 2.3: International Classification of Disease Classification of Visual Impairment, 2016
  • Table 2.4: The US Classification of Medical Devices
  • Table 2.5: The EU Classification of Medical Devices
  • Table 2.6: The Japanese Classification of Medical Devices
  • Table 3.1: The Global Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 3.2: Ophthalmic Devices Market Overview by Submarket: Revenue ($bn) and Market Share (%), 2015
  • Table 3.3: The Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 4.1: The Ophthalmic Surgical Devices Market by Segment: Revenue ($bn) and Market Share (%), 2015
  • Table 4.2: The Ophthalmic Surgical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 4.3: The Intraocular Lenses Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 4.4: Types of Premium IOLs on the Market, 2016
  • Table 4.5: The Ophthalmic Laser Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 4.6: The Ophthalmic Viscoelastic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 4.7: The Phacoemulsification Devices Market Forcast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 4.8: The Other Ophthalmic Surgical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 4.9: SWOT Analysis of the Ophthalmic Surgical Devices Market, 2016-2026
  • Table 5.1: The Vision Care Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 5.2: The Ophthalmic Vision Care Devices Market by Segment: Revenue ($bn) and Market Share (%), 2015
  • Table 5.3: The Ophthalmic Vision Care Market Forecast by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 5.4: The Daily Disposable Contact Lenses Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 5.5: The Other Contact Lenses Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 5.6: Leading Silicone Hydrogel Contact Lenses Products in the Market, 2016
  • Table 5.7: SWOT Analysis of the Vision Care Devices Market , 2016-2026
  • Table 6.1: The Ophthalmic Diagnostics and Monitoring Market by Segment: Revenue ($bn) and Market Shares (%), 2015
  • Table 6.2: The Ophthalmic Diagnostics and Monitoring Market Forecast by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 6.3: The OCT Machine Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 6.4: Leading Ophthalmic OCT Machines in the Market, 2016
  • Table 6.5: The Autorefractor/Keratometer Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 6.6: The Fundus Camera Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 6.7: The Slit Lamp Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 6.8: The Other Ophthalmic Diagnostics and Monitoring Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 6.9: SWOT Analysis of the Ophthalmic Diagnostics and Monitoring Devices Market , 2015-2026
  • Table 7.1: The Ophthalmic Devices Market by Region: Revenue ($bn), and Market Share (%), 2015
  • Table 7.2: The Ophthalmic Devices Market by Region: Revenue ($bn), and Market Share (%), 2026
  • Table 7.3: The Leading National Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.4: The US Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.5: The European Ophthalmic Devices Market by Country: Revenue ($bn) and Market Share (%), 2015
  • Table 7.6: The EU5 Ophthalmic Devices Market by Country Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.7: The German Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.8: The French Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.9: The UK Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.10: The Italian Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.11: The Spanish Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.12: The Japanese Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.13: The Chinese Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.14: The Indian Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.15: The Russian Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.16: The Brazilian Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 7.17: The South Korean Ophthalmic Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2026
  • Table 8.1: Alcon by Division: Revenue ($bn), 2014-2015
  • Table 8.2: Abbott Medical Optics: Product Line, 2016
  • Table 8.3: J&J Major Medical Devices: Revenue ($bn), Revenue Share (%) by Segment, 2015
  • Table 8.4: J&J Medical Devices by Segment: Revenue Share (%), 2015
  • Table 8.5: J&J Vision Care: Revenue ($bn), AGR (%), 2012-2015
  • Table 8.6: J&J Vision Care: Product Line by Wear Time, 2016
  • Table 8.7: J&J Vision Care: Product Line by Type of Refractive Error, 2016
  • Table 8.8: STAAR: Revenue ($m), AGR (%) and CAGR (%), 2012-2015
  • Table 8.9: STAAR: Product line
  • Table 8.10: Carl Zeiss Meditec: Revenue ($m), AGR (%) and CAGR (%) 2012-2014
  • Table 8.11: Carl Zeiss Meditec by Region: Revenue Share (%), 2015
  • Table 8.12: Carl Zeiss Meditec: Ophthalmic Product Line
  • Table 8.13: TopCon Eye Care Company: Revenue ($m), AGR (%) and CAGR (%), 2014-2014
  • Table 8.14: TopCon: Revenue ($bn), Revenue Share (%) by Division, 2015
  • Table 8.15: Haag-Streit: Medical Technology & Specialities

List of Figures

  • Figure 1.1: Ophthalmic Devices: Overview of Submarkets and Devices, 2016
  • Figure 2.1: Structure of the Human Eye
  • Figure 2.2: Global Prevalence of Visual Impairment, 2016
  • Figure 2.3: Global Share of Visual Impairment Among Different Age Groups, 2016
  • Figure 2.4: Global Causes of Visual Impairment (% of cases), 2014
  • Figure 3.1: The Global Medical Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 3.2: Ophthalmic Devices Market Overview by Segment: Revenue ($bn), 2015
  • Figure 3.3: Ophthalmic Devices Market Overview by Segment: Market Share (%), 2015
  • Figure 3.4: The Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 4.1: The Ophthalmic Surgical Devices Market by Segment: Revenue ($bn), 2015
  • Figure 4.2: The Ophthalmic Surgical Devices Market by Segment: Market Share (%), 2015
  • Figure 4.3: The Ophthalmic Surgical Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 4.4: The Intraocular Lenses Market Forcast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 4.5: The Ophthalmic Laser Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 4.6: The Ophthalmic Viscoelastic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 4.7: The Phacoemulsification Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 4.8: The Other Ophthalmic Surgical Devices Market: Revenue ($bn), and AGR (%), 2015-2026
  • Figure 4.9: Neurotech: Encapsulated Cell Technology Pipeline, 2016
  • Figure 4.10: Ocular Therapeutix: Punctum Plug Sustained Release Pipeline, 2016
  • Figure 5.1: The Vision Care Devices Market forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 5.2: The Ophthalmic Vision Care Devices Market by Segment: Revenue ($bn), 2015
  • Figure 5.3: The Ophthalmic Vision Care Devices Market by Segment: Market Share (%), 2015
  • Figure 5.4: The Ophthalmic Vision Care Market Forecast by Segment: Revenue ($bn), 2015-2026
  • Figure 5.5: The Daily Disposable Contact Lenses Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 5.6: The Other Contact Lenses Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 6.1: The Ophthalmic Diagnostics and Monitoring Market by Segment: Revenue ($bn), 2015
  • Figure 6.2: The Ophthalmic Diagnostics and Monitoring Devices Market by Segment: Market Share (%), 2015
  • Figure 6.3: The Ophthalmic Diagnostics and Monitoring Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 6.4: The OCT Machine Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 6.5: The Autorefractor/Keratometer Market Forecast: Revenue ($bn), and AGR (%), 2015-2026
  • Figure 6.6: The Fundus Camera Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 6.7: The Slit Lamp Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 6.8: The Other Ophthalmic Diagnostics and Monitoring Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.1: The Ophthalmic Devices Market by Region: Revenue ($bn), 2015
  • Figure 7.2: The Ophthalmic Devices Market by Region: Market Share (%), 2015
  • Figure 7.3: The Ophthalmic Devices Market by Region: Market Share (%), 2026
  • Figure 7.4: The US Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.5: The EU5 Ophthalmic Devices Market by Country: Revenue ($bn), 2016
  • Figure 7.6: The EU5 Ophthalmic Devices Market by Country: Market Share (%), 2015
  • Figure 7.7: The EU5 Ophthalmic Devices Market Forecast by Country: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.8: The German Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.9: The French Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.10: The UK Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.11: The Italian Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.12: The Spanish Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.13: The Japanese Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.14: The Chinese Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.15: The Indian Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.16: The Russian Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.17: The Brazilian Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 7.18: The South Korean Ophthalmic Devices Market Forecast: Revenue ($bn) and AGR (%), 2015-2026
  • Figure 8.1: Alcon by Division: Revenue Share (%), 2015
  • Figure 8.2: J&J Medical Devices by Segment: Revenue Share (%), 2015
  • Figure 8.3: Carl Zeiss Meditec by Business Unit: Revenue Share (%), 2015
  • Figure 8.4: Carl Zeiss Meditec by Region: Revenue Share (%), 2016
  • Figure 8.5: TopCon: Revenue Share (%) by Company, 2015
  • Figure 9.1: Porter's Five Forces Analysis of the Ophthalmic Devices Market, 2016-2026

Companies Listed

  • Abbott Medical Optics, Inc.
  • Alcon (Novartis International AG)
  • Alimera Sciences, Inc.
  • Allergan/Actavis PLC
  • Aquesys, Inc.
  • Bausch and Lomb (Valeant Pharmaceuticals International, Inc.)
  • Calhoun Vision, Inc.
  • Canon, Inc.
  • Carl Zeiss Meditec AG
  • CooperVision
  • Essilor International S.A.
  • Forus Health Pvt. Ltd.
  • Genentech, Inc.
  • Glaukos Corporation
  • Google, Inc.
  • Heidelberg Engineering GmbH
  • Hoya Corporation
  • InSight
  • Ivantis, Inc.
  • Johnson & Johnson
  • LENSAR, Inc.
  • Marco
  • Medennium, Inc.
  • NeoMedix Corporation
  • Neurotech Pharmaceuticals, Inc.
  • Nidek Co., LTD.
  • Nikon Corporation
  • Novartis International AG
  • NuLens
  • Ocular Therapeutix, Inc.
  • Optovue, Inc.
  • Oraya Therapeutics International, Inc.
  • OSI Pharmaceuticals, Inc.
  • PowerVision, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Seiko Epson Corporation
  • Sensimed SA
  • Shanghai Weicon Optics Co., LTD.
  • STAAR Surgical Co.
  • Taiwan Liposome Company Ltd.
  • TopCon Corporation
  • Tomey Corporation
  • Transcent Medical, Inc.
  • Vision Solution Technologies, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • WaveTec Vision (Novartis International AG)

Organisations Mentioned in this Report

  • Food and Drug Administration (US)
  • Japanese Ministry of Health, Labour, and Welfare (MHLW)
  • Japanese Pharmaceutical and Medical Devices Agency (PMDA)
  • Mexican National Institute of Statistics and Geography (INEGI)
  • US Preventive Service Task Force (USPSTF)
  • World Health Organization (WHO)
Back to Top